Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Watchlist
Price: 3.29 USD 1.86% Market Closed
Market Cap: $4.7B

Operating Margin

14.7%
Current
Improving
by 4.3%
vs 3-y average of 10.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.7%
=
Operating Income
¥788.6m
/
Revenue
¥5.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.7%
=
Operating Income
$788.6m
/
Revenue
¥5.4B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
34.6B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.6B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...

Market Distribution

Higher than 80% of companies in China
Percentile
80th
Based on 8 544 companies
80th percentile
14.7%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Glance View

Market Cap
4.7B USD
Industry
Pharmaceuticals

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, rooted in the rich tapestry of traditional Chinese medicine, has carved out a substantial presence in the pharmaceutical industry. Established in a region known for its deep cultural heritage in holistic healing, the company seamlessly weaves ancient practices with modern scientific advancements. At the core of its operations, Da Ren Tang specializes in the research, development, production, and distribution of traditional Chinese medicine and pharmaceuticals. Beyond just leveraging ancient recipes, the company invests significantly in cutting-edge research to validate and enhance the efficacy of its formulations, gaining trust not only domestically but also in international markets. This blending of tradition and innovation enables Da Ren Tang to capture a diverse customer base, ranging from individuals seeking natural remedies to medical institutions incorporating holistic approaches into patient care. The economic engine of Da Ren Tang powers through a multi-faceted monetization strategy. It manufactures a broad portfolio of pharmaceutical products, including patented Chinese medicines and active pharmaceutical ingredients (APIs), which are distributed through a well-established network of pharmacies and healthcare providers. Additionally, the company has embraced the digital era by exploring e-commerce platforms, thereby expanding its reach and accessibility to tech-savvy consumers globally. By maintaining stringent quality controls and adopting sustainable practices in its production processes, Da Ren Tang not only enhances its reputation but also adheres to evolving regulatory standards worldwide. Such strategic positioning allows the company to capitalize on the growing global interest in traditional medicines, contributing significantly to its revenue streams and reinforcing its status as a prominent player in the pharmaceutical landscape.

T14 Intrinsic Value
2.22 USD
Overvaluation 33%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.7%
=
Operating Income
¥788.6m
/
Revenue
¥5.4B
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's current Operating Margin?

The current Operating Margin for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 14.7%, which is above its 3-year median of 10.4%.

How has Operating Margin changed over time?

Over the last 3 years, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd’s Operating Margin has increased from 9.1% to 14.7%. During this period, it reached a low of 8.3% on Dec 31, 2022 and a high of 14.7% on Oct 30, 2025.

Back to Top